The process as claimed in claim 1, wherein PGi represents a protecting group selected from alkyloxy carbonyl such as methoxy carbonyl, ethoxy carbonyl, tert.butoxycarbonyl (Boc)
Cascone T, Leung CH, Weissferdt A, Pataer A, Carter BW, Godoy MCB, Feldman H, William WN Jr, Xi Y, Basu S, Sun JJ, Yadav SS, Rojas Alvarez FR, Lee Y, Mishra AK, Chen L, Pradhan M, Guo H, Sinjab A, Zhou N, Negrao MV, Le X, Gay CM, Tsao AS, Byers LA, Altan M, Glisson BS, Fossella FV, Elamin YY, Blumenschein G Jr, Zhang J, Skoulidis F, Wu J, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Rajaram R, Antonoff MB, Fujimoto J, Solis LM, Parra ER, Haymaker C, Wistuba II, Swisher SG , Vaporciyan AA, Lin HY, Wang J, Gibbons DL, Jack Lee J, Ajami NJ, Wargo JA, Allison JP, Sharma P, Kadara H, Heymach JV, Sepesi B
(5.1) Pancreatitis: There have been postmarketing reports of acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis
Descripcin RTD GLP-1 GIP Glucagn Pptido: RETATRUTIDE Concentracin: 10 mg 20 mg 30 mg Control avanzado del peso Optimizacin metablica Accin triple
Among semaglutide patients who stayed on treatment, average weight loss reached 11.9%, much closer to the trial result
10mg vial / 4mg per week = 2.5 weeks